Drug-Coated Balloon
Survival After Coronary Revascularization With Paclitaxel-Coated Balloons | Journal of the American College of Cardiology
Drug-eluting Balloons Enter the U.S. Market | DAIC
Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial | SpringerLink
Drug-eluting balloon versus bare-mental stent and drug-eluting stent for de novo coronary artery disease: A systematic review and meta-analysis of 14 randomized controlled trials | PLOS ONE
Drug-coated Balloons for Small Coronary Vessel Interventions: A Literature Review | ICR Journal
Second‐generation drug‐eluting stents versus drug‐coated balloons for the treatment of coronary in‐stent restenosis: A systematic review and meta‐analysis - Kokkinidis - 2018 - Catheterization and Cardiovascular Interventions - Wiley Online Library
Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries - ScienceDirect
Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease | Journal of the American College of Cardiology
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis - ScienceDirect
Frontiers | The factors influencing the efficiency of drug-coated balloons
Clinical Application of Drug-Coated Balloon in The Treatment of Coronary Artery Disease - Kossel Medtech
Drug-Coated Balloon
Drug-eluting balloon: design, technology and clinical aspects
Drug-Eluting Stents | Circulation
5-year results of cutting or scoring balloon before drug-eluting balloon to treat in-stent restenosis | Ischemic heart disease | Original article
Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trial | SpringerLink
PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease | tctmd.com
Drug Eluting Balloon Market Size, Growth, Trends and Forecast to 2028 | Medtronic, Becton, Boston Scientific Corporation | Medgadget
Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease | USC Journal
In.Pact Admiral Demonstrates Durability, Safety and Efficacy at Three Years | DAIC
Summary of the efficacy of paclitaxel-coated balloon angioplasty vs.... | Download Scientific Diagram
Drug-eluting balloon technology: the three components. | Download Scientific Diagram
EuroPCR 2021: Drug-coated Balloons vs Drug Eluting Stents
